AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05820698 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The UK diet
Description: Participants in the UK diet with time-restricted eating group will be provided with recommendations of a nutritionally balanced diet, corresponding to the average intakes of the UK population. Participants will be advised to consume no more than 4 portions of fruits and vegetables combined per day, to have at least two servings of dairy per day, to limit the consumption of white fish to less than 1 serving per week, with ≤1 serving of oily fish per month. Nuts and seeds consumption should also be limited to ≤1 serving per week and at least 3 servings of white and red meat should be consumed per week.~Participants randomised to the UK diet will be provided with support documents including a dietary guideline booklet, recipes, and meal plans. A £30 reimbursement will be provided to participants for their grocery shopping on week 1, week 4, and week 8 of the study.
Study NCT05820698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time-restricted eating
Description: Participants randomised to the time-restricted eating interventions will be advised to limit food intake to a 10-hour eating window and to abstain from food intake for a 14-hour fasting window. Hydration is to be maintained during the fasting window with water and/or plain teas/coffees
Study NCT05820698 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Time-restricted eating
Description: Participants randomised to the time-restricted eating interventions will be advised to limit food intake to a 10-hour eating window and to abstain from food intake for a 14-hour fasting window. Hydration is to be maintained during the fasting window with water and/or plain teas/coffees
Study NCT05179083 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-Impact Aerobic Exercise
Description: Participants will be submitted to a 12-week high-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (80% of maximum) is reached, followed by 10 minutes of cool down.
Study NCT05179083 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low-Impact Aerobic Exercise
Description: Participants will be submitted to a 12-week low-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (40% of maximum) is reached, followed by 10 minutes of cool down.
Study NCT05039671 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Measurement-based care (MBC)
Description: Clinicians will receive a 3-hour interactive MBC training followed by six months of post-training consultation. Training and consultation will include how to collect, score, and use student- and parent-reported progress measures with students and families to inform collaborative progress monitoring and treatment decisions.
Study NCT04814368 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: canakinumab
Description: intra-articular injection (into the knee)
Study NCT04814368 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LNA043
Description: intra-articular injection (into the knee)
Study NCT04814368 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo to canakinumab
Description: intra-articular injection (into the knee)
Study NCT04814368 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to canakinumab
Description: intra-articular injection (into the knee)
Study NCT06461533 — intervention group
Intervention type: DRUG
Intervention: Susoctocog Alfa (Genetical Recombination)
Description: Susoctocog Alfa (Genetical Recombination), Intravenous injection
Study NCT05202509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obicetrapib
Description: 10mg obicetrapib tablet
Study NCT05202509 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet to resemble obicetrapib
Study NCT05248542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Usage on Oral Care Knowledge
Description: Virtual Reality Usage on Oral Care Knowledge about independent older adults
Study NCT04041804 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: semirapid maxillary expansion (SRME)
Description: A Banded Hyrax is going to be used in order to provide an increase in the maxillary transverse dimension
Study NCT06430203 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer mentoring
Description: Indigenous young adult peer mentors who will develop and deliver the program based on needs and wants of our participants. The program will be built on their experience and ideas. They will be empowered to guide the program in the direction they see best for their communities.
Study NCT04888156 — intervention group
Intervention type: OTHER
Intervention: Unchanged treatment
Description: Treatment is the same pre- and post self-tonometry
Study NCT05649891 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emergency Manual
Description: Collection of crisis checklists and fact sheets
Study NCT05376397 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iTHRIVE 365
Description: iTHRIVE 365 is a multicomponent intervention that combines mHealth features and institutional to support community priorities identified in formative CBPR. In line with best-practices for trials of intervention principles (TIPs) of interventions with mHealth features, THRIVE 365 deploys intervention elements that serve to accomplish intervention strategies. THRIVE 365 intervention strategies are to promote: 1)Health knowledge and motivation; 2)Social support coping; 3)Access to culturally-affirming healthcare; and 4)Housing and other economic resources. THRIVE 365 pursues these strategies via these intervention elements: 1)Weekly HIV and psychological health information and motivation content and daily health notifications; 2)Online moderated forums, interpersonal chats, and community calendars; 3)Linkage to biopsychosocial healthcare via THRIVE SS's network of BSMM-affirming providers; and 4)Housing and economic resources through THRIVE SS's direct support and referral network.
Study NCT04806100 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Malleo-Lok
Description: The Malleo-Lok is a novel, low-profile carbon fiber device with two laterally positioned struts aligned in the sagittal plane.
Study NCT04888156 — intervention group
Intervention type: OTHER
Intervention: Changed treatment
Description: Treatment is changed post self-tonometry
Study NCT05277285 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Thiosulfate 25% Solution for Injection
Description: The drug will be administered via continuous infusion after being diluted to a concentration 12.5 gr/100ml
Study NCT05846542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video-game based therapy
Description: Video-game based therapy will be designed for the individual basis for the upper extremity.
Study NCT05846542 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy within a specific program
Study NCT05846542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy within a specific program
Study NCT06128642 — intervention group
Intervention type: DEVICE
Intervention: Toe separator orthosis
Description: The orthoses to be used during the study will be randomly distributed to the individuals participating in the study. Foot pressure analysis will be evaluated after the participants use the toe separation orthosis for 8 hours a day, for a total of 1 month.~Plantar pressure analysis will be performed again without orthosis, with orthosis and 1 month after the use of orthosis. Additionally, patient orthosis satisfaction evaluation will be made at the end of the 1-month period during which the participants use the orthoses.
Study NCT00415649 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VRC-HIVDNA016-00-VP
Study NCT00415649 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VRC-HIVADV014-00-VP
Study NCT00415649 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Vaccine placebo
Description: Placebo comparator
Study NCT04454476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib treatment
Description: 1 mg taken by mouth once a day for 14 days
Study NCT04454476 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopy
Description: A tiny camera on the end of a long, flexible tube will be used to examine the stomach and take biopsies.
Study NCT06128642 — intervention group
Intervention type: DEVICE
Intervention: Dynamic orthosis
Description: The orthoses to be used during the study will be randomly distributed to the individuals participating in the study. Foot pressure analysis will be evaluated after participants use the dynamic orthosis for 8 hours a day, for a total of 1 month.~Plantar pressure analysis will be performed again without orthosis, with orthosis and 1 month after the use of orthosis. Additionally, patient orthosis satisfaction evaluation will be made at the end of the 1-month period during which the participants use the orthoses.
Study NCT05037305 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Educational video
Description: The brief educational video provides information about pharmacogenetic testing, the results of pharmacogenetic testing, and how to find these results in the patient portal.
Study NCT05350150 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auricular Vagal Nerve Stimulation
Description: The Parasym device will be placed on the patient's left tragus to provide transcutaneous electrical stimulation to the auricular branch of the vagus nerve.
Study NCT06526637 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Paper Package
Description: Paper based (as per current practice at Central and North West London (CNWL) NHS Foundation Trust) version of Palliate.
Study NCT06526637 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: V1 + Preparation Sheet
Description: Paper based version of Palliate plus a preparation sheet, that provides visual cues as to what equipment is required for the preparation and administration of the medications.
Study NCT06526637 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: V2 + Video Training
Description: Hybrid - paper based materials, preparation sheet, and video instructions available via an interactive portable document format (PDF) version of the training materials.
Study NCT06193837 — intervention group
Intervention type: DRUG
Intervention: Augmentin
Description: Use of prophylactic antibiotics in lap cholecystectomy
Study NCT06180590 — intervention group
Intervention type: DRUG
Intervention: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
Description: Evaluate the efficacy of Vosevi in DAAs-experienced patients
Study NCT06493695 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Both EGChat and CES intervention
Description: 1. A exercise-promoting chatbot called EGChat, integrated into an established online health promotion platform.~2. Intervention of CES (Cranial Electrotherapy Stimulation) at Home
Study NCT06493695 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Chatbot
Description: Exercise Chatbot
Study NCT06493695 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CES (Cranial Electrotherapy Stimulation)
Description: Intervention of CES (Cranial Electrotherapy Stimulation)
Study NCT05099718 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: palatal soft tissue harvesting
Description: A 6x2mm palatal soft tissue graft will be harvested.
Study NCT05099718 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: palatal soft tissue harvesting
Description: A 6x2mm palatal soft tissue graft will be harvested.
Study NCT05099718 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: application 3-times per day for 7 days
Study NCT05099718 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline solution (placebo)
Description: application 3-times per day for 7 days
Study NCT04444323 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D Telemedicine
Description: The intervention is a consultation conducted using a 3D form of telemedicine
Study NCT04837768 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Twice-daily transvaginal progesterone supplementation
Description: Patients with serum progesterone levels >9.2 ng/ml on the day of embryo transfer in artificial frozen cycles will receive the traditional twice-daily vaginal progesterone supplementation till 12 weeks gestation.
Study NCT04837768 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Twice-weekly intramuscular + Twice-daily transvaginal progesterone supplementation
Description: Patients with serum progesterone levels \<9.2 ng/ml on the day of embryo transfer in artificial frozen cycles will receive the twice-daily vaginal progesterone in addition to twice-weekly intramuscular progesterone supplementation till 12 weeks gestation.
Study NCT05387863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) Web Tool
Description: The DA web tool provides information on kidney masses and available treatment options. It uses risk communication, directed teaching, and interactive benefit-harm assessment to present information.
Study NCT05387863 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Institutional Pamphlet
Description: The institutional pamphlet provides information on kidney masses, but does not use risk communication, directed teaching, or interactive benefit-harm assessment.
Study NCT06009666 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Shear Wave Elastography and B Mode Ultrasonography
Description: We evaluated the both upper extremities of the patient and control group with elastography and B mode ultrasonography. Shear wave elastography evaluates tissue deformation caused by acoustic radiation force. A highly focused ultrasound radiation is produced; The propagation speed of the shear wave depends on the stiffness of the tissue. It is a simple, inexpensive, bedside, widely available, non-invasive technique. B mode USG can be used to assess skin and subcutaneous tissue thickness and echogenicity. Skin and subcutaneous thickness were measured with b mode ultrasound. Skin and subcutaneous tissue stiffness was measured by shear wave ultrasonography
Study NCT06009666 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Quick Dash Questionnare
Description: Quick-DASH is an assessment questionnaire that measures activity and participation limitations in all upper extremity disorders. In the questionnaire, the difficulties of the patients during their daily living activities are questioned with 11 questions. Each answer is scored from 1 to 5 on a Likert scale, from best to worst.
Study NCT06009666 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: The Lymphedema Life Impact Scale
Description: The Lymphedema Life Impact Scale is a questionnaire developed to evaluate the physical, functional and psychosocial effects of lymphedema. It consists of 18 questions; It includes 8 physical, 4 psychosocial and 6 functional subgroups. Each question is scored from 1 to 5, with higher scores indicating increased seriousness.
Study NCT06009666 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Questioning lymphedema-related symptoms
Description: Arm pain and feeling of tension, heaviness and stiffness in the arm were evaluated separately by numerical scale. This scale is a 10 cm ruler that writes no pain, no tension, no heaviness, no stiffness on one side, and unbearable pain, tension and heaviness on the other side. Patients were asked to rate their associated symptoms on this scale between 0 and 10.
Study NCT06009666 — intervention group
Intervention type: OTHER
Intervention: Extremity circumference and volume measurement
Description: For the diagnosis of lymphedema, a detailed physical examination and extremity circumference were measured. This measurement was taken from both wrists to arm height with 4 cm intervals. Those with a circumference difference greater than 2 cm and/or no 10% volume difference were considered preclinical (latent) and those with clinical lymphedema.
Study NCT04329598 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-Body Electromyostimulation Group
Description: Whole-Body Electromyostimulation group includes exercises with electric stimulation. Whole-Body Electromyostimulation group will have 45 minutes of exercises which are specific exercises for Lumbar Disc Herniation.
Study NCT04329598 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Group
Description: Exercise group includes exercises without electric stimulation. Exercise group will have 45 minutes of exercises which are specific exercises for Lumbar Disc Herniation.
Study NCT06180681 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Team-Enhanced Collaborative Life Skills Program
Description: We will integrate three team-based implementation strategies to enhance team effectiveness in CLS, including Team Charters, Team Communication Training via Student Handoff Protocols, and Team Performance Monitoring. These interventions have been shown to improve cognitive (e.g., shared mental models) and affective ((e.g., trust, collective efficacy) team-based emergent states and enhance team-based processes, such as communication and coordination.
Study NCT06180681 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Collaborative Life Skills Program
Description: CLS is a school-delivered intervention coordinating three empirically-supported approaches: teacher consultation and a daily behavior report card, behavioral parent training and child skills training. The three components are integrated over a 10-12 week period to improve symptoms and functional impairment among youth with ADHD.
Study NCT06203860 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cardio-Metabolic Clinic
Description: The Cardio-Metabolic Clinic will adhere to a standardized evaluation and treatment program based on the latest treatment guidelines from the European Cardiovascular Society. The assessment will include the following points:~* Lipid management~* Blood pressure management~* Antithrombotic therapy~* Glycemic targets~* Prevention of diabetes-related complications~* Treatment of vascular disease affecting the lower extremities~* Evaluation of cardioprotective drugs~* Counseling on lifestyle factors, including diet, smoking, alcohol, and exercise~* Guidance on vaccinations
Study NCT06497920 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active rTMS to the motor cortex
Description: Active bilateral repetitive transcranial magnetic stimulation to the motor cortex
Study NCT06497920 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS to the motor cortex
Description: Sham bilateral repetitive transcranial magnetic stimulation to the motor cortex
Study NCT05519852 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates training
Description: the pilates group (20 patients) will be trained 30 minutes of pilates exercise (before it there will be warm up period and after it there will be cooldown period , each will be 5 minutes). the pilates will be repeated five sessions per the week for 3 months
Study NCT05234424 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: THRIVE
Description: During general anesthesia, apneic oxygenation with a high flow nasal oxygen system is applied for 10 minutes. Video laryngoscopy will be performed to achieve similar airway patency.
Study NCT05234424 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: THRIVE
Description: During general anesthesia, apneic oxygenation with a high flow nasal oxygen system is applied for 10 minutes. Video laryngoscopy will be performed to achieve similar airway patency.
Study NCT04691011 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Muscular MRI
Description: MRI (1.5T)
Study NCT04691011 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Electrophysiological exam
Description: MUNIX
Study NCT04691011 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Brain MRI
Description: MRI (7T)
Study NCT04691011 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Spinal cord MRI
Description: 7T and 3T MRI
Study NCT06183060 — intervention group
Intervention type: PROCEDURE
Intervention: endotracheal intubation
Description: all patients will receive laryngoscopy and endotracheal intubation
Study NCT05807776 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab 200mg, iv, d1, Q3W
Study NCT05807776 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab, Lenvatinib
Description: Tislelizumab combined with lenvatinib:~Tislelizumab 200mg, iv, d1, Q3W Lenvatinib 8mg，po，qd.
Study NCT06238349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral bifidobacterium triple live powder
Description: The newborns in the Bifidobacterium group will receive all interventions prescribed for the control group, and also were assigned to orally be given Bifidobacterium triple viable powder (Shanghai Xinyi Pharmaceutical Company, Peifeikang powder, 0.5 g/dose, 3 times/day. Bifidobacterium triple viable powder contains live bacteria of long Bifidobacterium at no less than 1.0 × 107 CFU/g, stored at 2.8℃ away from light) beginning within 24 hours after birth and continuing for 1 week. No sunbathing will be prescribed.